• Login
Wednesday, April 22, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Switzerland

What will be the next obesity blockbuster?

GenevaTimes by GenevaTimes
April 22, 2026
in Switzerland
Reading Time: 4 mins read
0
What will be the next obesity blockbuster?
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


The latest weight loss drugs like Wegovy and Mounjaro have changed the lives of many people with obesity. What will the next generation of obesity drugs look like?


This content was published on


April 22, 2026 – 11:50


I report on the Swiss pharmaceutical industry and healthcare topics such as access to medicine, biomedical innovation, and the impact of diseases like cancer.
I grew up just outside San Francisco and studied international affairs with a focus on development economics and healthcare policy. Prior to joining SWI swissinfo.ch in 2018, I was a freelance journalist and a researcher on business and human rights.




  • More from this author



  • English Department


My work focuses on engaging with you, our audience, and strengthening trust in our journalism. I develop engagement tools such as multilingual debates and help distribute our content to users across platforms.
A former nurse, I later pursued English linguistics and media studies where I developed a keen interest in journalism and news in the digital age.




  • More from this author



  • English Department

Two companies – Danish maker Novo Nordisk and US pharma company Eli Lilly – have dominated the market for obesity drugs.

But there are now dozens of big and small companies, including some Swiss ones, that are hoping to challenge them with a new generation of obesity drugs.

More

injection pen

More


New treatments

Can Swiss pharma giant Roche reshape the obesity market?




This content was published on


Apr 2, 2026



Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking into a highly competitive market.



Read more: Can Swiss pharma giant Roche reshape the obesity market?


What are your thoughts or questions on weight loss drugs?

Articles in this story

Read More

Previous Post

AstraZeneca warns German reforms could push pharma launches and investment out of Europe

Next Post

South Korean fighter jets collided due to pilots taking pictures, report finds

Next Post
South Korean fighter jets collided due to pilots taking pictures, report finds

South Korean fighter jets collided due to pilots taking pictures, report finds

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin